Novo Nordisk | Beneficio Operativo



Operating Profit Cambio Fecha
ANI Pharmaceuticals USD 26.19M 30.57M 2025-03
Aurora Cannabis CAD 36.22M 38.61M 2024-12
Bausch Health Companies USD 457M 181M 2025-06
Bristol-Myers Squibb USD 3.77B 366M 2025-06
Canopy Growth CAD -23822000 21.8M 2024-12
Corcept Therapeutics USD 26.67M 23.26M 2025-06
Drreddys Laboratories INR 18.72B 1.17B 2024-12
Eli Lilly USD 5.41B 259.6M 2025-03
GlaxoSmithKline GBP 2.02B 193M 2025-06
Merck USD 6.36B 494M 2025-06
Novartis USD 4.86B 201M 2025-06
Novo Nordisk 38.79B 4.97B 2025-03
Novo Nordisk DKK 38.79B 4.97B 2025-03
Pacira USD 1.99M 22.71M 2025-03
Perrigo USD 79.4M 33.3M 2025-03
Prestige Brands USD 88.43M 3.53M 2025-03
Sanofi EUR 1.71B 573M 2025-06
Supernus Pharmaceuticals USD 21.4M 19.44M 2024-12
Zoetis USD 810M 78M 2025-03


Novo Nordisk Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.